Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA

NCT05103618 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped funding not obtained

Conditions

Parkinson Disease
Idiopathic Parkinson Disease

Interventions

DRUG: [F-18] Fluorodopa Positron Emission Tomography
BEHAVIORAL: OM Meditation

Sponsor

Andrew Newberg